title: The specific monocarboxylate transporter (MCT1) inhibitor, AR-C117977, a novel immunosuppressant, prolongs allograft survival in the mouse.
abstract: Novel small molecular weight compounds that act by inhibiting the monocarboxylate transporter (MCT1) receptor have been found to cause profound inhibition of T-cell responses to alloantigen in vitro. Here, we have investigated the ability of one compound in this series, AR-C117977, a potent MCT1 inhibitor, to prevent the acute and chronic rejection of vascularized and nonvascularized allografts in the mouse. Treatment with AR-C117977 or cyclosporin A (CsA) administered at a dose of 30 mg/kg subcutaneously for 15 days to adult CBA. Ca (H2(k)) mice, commencing either 3 days or 1 day before transplantation, was found to prolong the survival of an allogeneic (C57BL/10 H2(b); NZW H2(z); or BALB/c H2(d)) heart, aorta, or skin allograft significantly compared with treatment with vehicle alone (median survival time [MST] AR-C117977 treated 15; 19 and 18 days [skin] and 73; 66 and 67 days ([heart] vs. vehicle treated 8, 8 and 9 days [skin] and 9, 8, 10 days [heart] for B10, NZW and BALB grafts, respectively). AR-C117977 also inhibited the development of transplant arteriosclerosis in aortic allografts partially, but was unable to inhibit alloantibody production after transplantation. The specific MCT1 inhibitor AR-C117977 has potent immunosuppressive properties in vivo effectively preventing acute but not chronic allograft rejection in the mouse.
authors.affiliation: Transplantation Research Immunology Group, Nuffield Department of Surgery, John Radcliffe Hospital, Oxford, UK.
authors.forename: Valquiria
authors.initials: V
authors.lastname: Bueno
authors.forename: Isabelle
authors.initials: I
authors.lastname: Binet
authors.forename: Ulrich
authors.initials: U
authors.lastname: Steger
authors.forename: Robert
authors.initials: R
authors.lastname: Bundick
authors.forename: Douglas
authors.initials: D
authors.lastname: Ferguson
authors.forename: Clare
authors.initials: C
authors.lastname: Murray
authors.forename: David
authors.initials: D
authors.lastname: Donald
authors.forename: Kathryn
authors.initials: K
authors.lastname: Wood
mesh_terms: D000818:Animals; D001011:Aorta / Q000637:transplantation*; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D016027:Heart Transplantation / Q000276:immunology*; D006571:Heterocyclic Compounds / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007518:Isoantibodies / Q000097:blood*; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D027501:Monocarboxylic Acid Transporters / Q000037:antagonists & inhibitors*; D027981:Symporters / Q000037:antagonists & inhibitors*; D014184:Transplantation, Homologous / Q000276:immunology*; D000099233:Monocarboxylate Transport Protein 1
chemical_list: D006571:Heterocyclic Compounds; D007166:Immunosuppressive Agents; D007518:Isoantibodies; D027501:Monocarboxylic Acid Transporters; D027981:Symporters; D000099233:Monocarboxylate Transport Protein 1; C525748:AR C117977